Clinical Trial Update: A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults [Phase 3]

View source ↗

Summary

Pfizer is conducting a Phase 3 trial to study different dosing schedules of a Lyme disease vaccine (VLA15) in healthy adults. The study is currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lyme Disease

Drugs mentioned

• VLA15

Snippet

Sponsor: Pfizer | Conditions: Lyme Borreliosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING